DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. BCRP Research Highlights/News
  3. 2011 Breast Cancer Research Program

NEWS RELEASE

Released: December 9, 2010

Department of Defense Breast Cancer Research Program
Anticipated Funding Opportunities for Fiscal Year 2011 (FY11)

The Department of Defense Breast Cancer Research Program (BCRP) is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

Congressional funds for the Fiscal Year 2011 (FY11) BCRP have not yet been appropriated. However, the BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. The BCRP anticipates offering the following award mechanisms for FY11 pending availability of congressional funds. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Postdoctoral Fellowship Award Principal Investigator (PI): Doctoral graduates (PhD or MD). Clinical investigators are eligible to apply. Must have no more than 2 years in the proposed research setting and no more than 4 years of postdoctoral research experience as of the application deadline.

Mentor or formal co-mentor must have breast cancer research experience, including funding (past or current) and publications.
  • Supports the training of exceptionally talented recent doctoral graduates.
  • Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research.
  • Proposed research should be innovative and address a critical problem in breast cancer research.
  • Multidisciplinary training encouraged.
  • Maximum funding of $300K for direct costs ($100K per year; plus indirect costs).
  • Period of performance not to exceed 3 years.
Era of Hope Scholar Award Independent, non-mentored investigators within 6 years of their last mentored position as of the application submission deadline.
  • Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields.
  • Individuals should exhibit strong potential for leadership in the breast cancer community.
  • Maximum funding of $2.5M for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
Innovator Award Associate Professor or above (or equivalent).
  • Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.
  • Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer.
  • Maximum funding of $5M for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
Transformative Vision Award Independent investigators at any academic level (or equivalent).
  • Supports a coordinated translational research effort involving multiple PIs to answer a question of major importance in breast cancer prevention or treatment as quickly as possible.
  • Teams must include consumer advocates who will be integrated into the planning and implementation of the research project.
  • Regular in-person meetings among all team members will be required.
  • Preproposal is required; application submission is by invitation only.
  • Maximum funding of $12M for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
Idea Award (REVISED!) Independent investigators at any academic level (or equivalent).
  • Supports research that has extraordinary potential to yield highly impactful data and lead to critical discoveries or major advancements in breast cancer.
  • Impact is the most important review criterion. Innovation is encouraged, but not required.
  • Preliminary data is allowed, but not required.
  • Collaborative Option supports combining expertise of two PIs to more effectively address a research question.
  • Preproposal is required; limit of 1 preproposal per PI; application submission is by invitation only.
  • Maximum funding of $500K for direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.

All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (https://CDMRP.HEALTH.MIL).

Point of Contact: